Early Results Are Positive from Experimental CRISPR Therapies

Two clinical trial participants--one with beta-thalassemia and one with sickle cell disease--appeared to benefit from the gene-editing treatments with minimal side effects, according to the companies.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news